Vor Biopharma Inc. · NASDAQ:VOR
Great Point Partners LLC's stake in Vor Biopharma Inc. fell to 3.30% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 17, 2026
Great Point Partners LLC's stake in Vor Biopharma Inc. fell to 3.30%, 1,370,107 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).
- Stake
- 3.30%
- Shares
- 1,370,107
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Great Point Partners, LLC | 3.30% | 1,370,107 |
| Dr. Jeffrey R. Jay, M.D. | 3.30% | 1,370,107 |
| Ms. Lillian Nordahl | 3.30% | 1,370,107 |
Source
Related
- Vor Biopharma Inc.
- Great Point Partners LLC
- Vor Biopharma Inc. shareholders
- Schedule 13G · Great Point Partners LLC · Dec 17, 2025
- Form 4 · Ra Capital Management, L.P. · Oct 5, 2026
- Form 4 · RA Capital Healthcare Fund LP · Aug 26, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Verve Capital Limited · Aug 13, 2026